Comparing the Safety and Effectiveness of 4-Step Versus 6-Step Milk Ladders in Children Aged 1 to 5 With IgE-Mediated Cows Milk Protein Allergy
Led by Medical University of Warsaw · Updated on 2025-03-18
92
Participants Needed
2
Research Sites
12 weeks
Total Duration
AI-Summary
What this Trial Is About
Cows milk protein allergy CMPA is a common food allergy in young children, and the main treatment is avoiding cows milk proteins. Researchers are studying how children with IgE-mediated CMPA develop tolerance to cows milk proteins over time. This trial compares the effectiveness and safety of two milk introduction methods called the 4-step milk ladder 4-ML and the 6-step milk ladder 6-ML to see which better helps children build tolerance to cows milk.
Children aged 1 to 5 years with IgE-mediated CMPA will be randomly assigned to follow either the 4-step or 6-step milk ladder protocol. Both involve gradually introducing baked and non-heated milk products in increasing amounts with a 4-week break between each step. Oral food challenges OFCs will be done in the hospital at each step to test tolerance. The 4-ML group will be observed for 12 weeks, while the 6-ML group for 20 weeks.
During the study, children will be monitored for allergic reactions, including anaphylaxis and atopic dermatitis flare-ups, growth changes, and treatment adherence. Parents anxiety and quality of life will also be assessed. The main measurement is the percentage of children who tolerate non-heated cows milk proteins without reaction at the end of the observation period. The study will evaluate these outcomes through clinical tests and questionnaires over the treatment duration.
CONDITIONS
Brief Title
Effectiveness and Safety of Milk Ladders in Children with IgE-Mediated Cow's Milk Protein Allergy
Research Team
A
Andrea Horvath, MD, PhD
D
Daria Wiszniewska, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosis of IgE-mediated cow's milk protein allergy confirmed by oral food challenge or positive allergy tests in high-risk children
On a therapeutic elimination diet for cow's milk proteins for at least 6 months or up to 12 months of age
Eligible regardless of risk of anaphylaxis and asthma
Good overall health
Parents without language barriers
Written informed consent signed by parents
Good cooperation with child's guardians
You will not qualify if you...
Uncontrolled asthma with symptoms despite treatment
Signs of worsening chronic disease
Signs of acute infection such as runny nose, cough, or fever
Signs of worsening of other allergic diseases like conjunctivitis or atopic dermatitis
Anaphylaxis due to cow's milk proteins in the last 6 months
Use of antihistamines within 3-10 days before challenge
Already tolerant to baked cow's milk proteins or higher steps of the milk ladder
Use of immunosuppressive drugs or immunotherapy
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 12 weeks for 4-step milk ladder or 20 weeks for 6-step milk ladder
Participants introduce baked milk into their diet through either a 4-step or 6-step milk ladder, with oral food challenges conducted at each step in hospital settings to assess tolerance.
Multiple oral food challenge visits at each step with a 4-week break between steps
Follow-up
Duration - Up to the end of the 12 or 20 week observation period depending on study arm
Participants are observed for development of tolerance to non-heated cow's milk proteins and monitored for safety outcomes including allergic reactions and quality of life assessments.
Visits coincide with oral food challenges and assessments before and after each step
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Sensitization to Peach and Five Other Plant Allergens Using Skin Prick Tests
in Patients at Montpellier University Hospital
Study of Boiled Cashew Oral Immunotherapy to Treat Cashew Nut Allergy in Children Aged 2 to 17 Years
Randomized, Double-Blind Trial Comparing Boiled Cashew Therapy With Placebo
Comparing Clinical and Home Introduction of Cows Milk in Infants with Suspected Non-IgE-Mediated Cows Milk Allergy
Study to Understand Eosinophilic Disorders and Inflammation
Including Eosinophilic Gastrointestinal Disease and Food Allergy
Pilot Study Comparing Educational Approaches for Early Introduction and Continued Feeding of Allergenic Foods in Infants
Study of Omalizumab Treatment Effects on Skin Barrier in Children and Adults with Food Allergy
Phase IV Open-Label Trial Evaluating Skin Changes and Food Challenge Responses
Comparing the Safety and Effectiveness of 4-Step Versus 6-Step Milk Ladders in Children Aged 1 to 5 With IgE-Mediated Cows Milk Protein Allergy
Evaluating Low-dose Sesame Oral Immunotherapy for Children with Sesame Allergy in a Randomized Trial
Study of Oral Immunotherapy Using Cashew Nut Protein for Children With Cashew Allergy Ages 4 to 17
EmoTIChealth A Serious Game to Support Emotional Development and Health in Adolescents Ages 12 to 16 with and without Chronic Conditions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effectiveness and safety of the four-step versus six-step milk ladder in children with IgE-mediated cow's milk protein allergy: protocol for an open-label randomised controlled trial.
Daria Wiszniewska, Andrea Horvath, Agata Stróżyk...